TABLE 4. Most Common Drugs Listed as Principal Suspect (Serious or Fatal Outcome [Maternal Exposure Excluded])
| Drug or Product |
Cases |
Percentage |
Major Drug Class* |
|
| Palivizumab |
705 |
27.9 |
Immunologics |
| Cisapride |
102 |
4.0 |
Disorders, acid/peptic |
| Indomethacin |
97 |
3.8 |
NSAID |
| Nitric oxide |
86 |
3.4 |
Medicinal gases |
| Azithromycin |
52 |
2.1 |
Lincosamides/macrolides |
| Acetaminophen |
41 |
1.6 |
Analgesics, general |
| Fluconazole |
37 |
1.5 |
Antifungals |
| Ibuprofen |
33 |
1.3 |
NSAID |
| Respigam |
32 |
1.3 |
Immune serums |
| Ceftriaxone |
28 |
1.1 |
Cephalosporins |
| Cefaclor |
26 |
1.0 |
Cephalosporins |
| Cefoperazone |
25 |
1.0 |
Cephalosporins |
| Zidovudine |
25 |
1.0 |
Antivirals |
| Erythromycin |
22 |
0.9 |
Lincosamides/macrolides |
| Vincristine |
21 |
0.8 |
Antineoplastics |
| Sevoflurane |
20 |
0.8 |
Anesthetics, general |
| Vancomycin |
20 |
0.8 |
Antibacterials, miscellaneous |
|
NSAID indicates nonsteroidal antiinflammatory agent.
* Selected from FDA National Drug Code Directory.